Form 4 for CRTO Criteo S.A.
Accepted 2023-02-27 00:00:00 ET · period of report 2023-02-23 · accession 0001576427-23-000030 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-27 | 2023-02-23 | CRTO | Clarken Megan | CEO, Dir | A - Grant | $0.00 | +177.4K | 578.0K | +44% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-02-23 | A | A | 114,774 | $0.00 | 515,337 | D | — | — | (F1) The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share. (F2) The shares are subject to time-based vesting as follows: 50% of the shares will vest on the two-year anniversary of the grant date, and the remainder will vest in equal portions at the end of each quarter during the two-year period thereafter. (F3) For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). |
| 2 | Common | Ordinary Shares | 2023-02-23 | A | A | 62,640 | $0.00 | 577,977 | D | — | — | (F1) The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share. (F4) On February 24, 2022, the Reporting Person was granted performance-based stock units representing 140,239 shares of the Issuer at the target performance level, which would become eligible to vest based on the achievement of performance goals. On February 23, 2023, the achievement percentage was determined, resulting in 62,640 shares becoming eligible to time-based vesting as follows: 50% of the shares will vest on the two-year anniversary of the grant date, and the remainder will vest in equal portions at the end of each quarter during the two-year period thereafter. (F3) For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). |